BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial‐Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma
Open Access
- 7 December 2015
- journal article
- research article
- Published by Wiley in Stem Cells International
- Vol. 2016 (1) , 9714315
Abstract
Epithelial‐mesenchymal transition (EMT) is the underlying mechanism of tumor invasion and metastasis. Evidences from lung cancer cellular models show EMT can trigger conversion to a cancer stem cell (CSC) phenotype. In this study, we assessed mRNA expression levels of EMT‐inducing transcription factors (BMI1, TWIST1), CSC (CD133, ALDH1A1), and epithelial (EpCAM) markers in primary tumor and whole blood samples obtained from 57 patients with operable non‐small‐cell lung cancer (NSCLC) as well as in circulating tumor cells (CTCs) of 13 patients with metastatic disease; then possible associations between marker expressions were evaluated. In primary tumors as well as in whole blood, correlations between BMI1 and ALDH1A1 and between BMI1 and CD133 mRNA expressions were identified. No correlations between TWIST1 and CSC markers were observed. BMI1 mRNA expression in tumors positively correlated with BMI1 mRNA expression in blood. The immunohistochemical analysis confirmed coexpression of BMI1 and CSC markers in tumors. Gene expression profiling in CTCs revealed upregulated expression of EMT/CSC markers in CTCs. Our results suggest CSCs are present in both, tumor tissue and blood of NSCLC patients, whereas Bmi1 may play an important role in initiation and maintenance of CSCs and might be involved in the blood‐borne dissemination of NSCLC.Keywords
Funding Information
- Slovenian Research Agency (J3-4076)
This publication has 43 references indexed in Scilit:
- Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell–like Properties in Cancer CellsCancer Research, 2013
- Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancerOncology Reports, 2013
- Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinomaMedical Oncology, 2011
- The Emerging Role of EpCAM in Cancer and Stem Cell SignalingCancer Research, 2009
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung CancerMolecular Cancer Research, 2009
- Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray studyJournal of Cancer Research and Clinical Oncology, 2008
- Activation of Hepatic Stem Cell Marker EpCAM by Wnt–β-Catenin Signaling in Hepatocellular CarcinomaCancer Research, 2007
- The role of epithelial-mesenchymal transition in cancer pathologyPathology, 2007
- Applying the principles of stem-cell biology to cancerNature Reviews Cancer, 2003
- The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expressionBritish Journal of Cancer, 2001